REMEDY — Remedy Entertainment Oyj Income Statement
0.000.00%
Last trade - 00:00
- €226.60m
- €207.58m
- €33.93m
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | — | — | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.6 | 41.1 | 44.7 | 43.6 | 33.9 |
Cost of Revenue | |||||
Gross Profit | 29.5 | 39.6 | 38.4 | 31.8 | 15.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25.1 | 27.8 | 33.3 | 44.2 | 62.6 |
Operating Profit | 6.53 | 13.2 | 11.4 | -0.563 | -28.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.56 | 12.9 | 11.3 | -1.19 | -27.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.24 | 10.3 | 8.79 | -1.73 | -22.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.24 | 10.3 | 8.79 | -1.73 | -22.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.24 | 10.3 | 8.79 | -1.73 | -22.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.434 | 0.856 | 0.65 | -0.129 | -1.33 |
Dividends per Share |